These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35076666)

  • 1. Population-Based Penetrance of Deleterious Clinical Variants.
    Forrest IS; Chaudhary K; Vy HMT; Petrazzini BO; Bafna S; Jordan DM; Rocheleau G; Loos RJF; Nadkarni GN; Cho JH; Do R
    JAMA; 2022 Jan; 327(4):350-359. PubMed ID: 35076666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank.
    Biddinger KJ; Jurgens SJ; Maamari D; Gaziano L; Choi SH; Morrill VN; Halford JL; Khera AV; Lubitz SA; Ellinor PT; Aragam KG
    JAMA Cardiol; 2022 Jul; 7(7):715-722. PubMed ID: 35583889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.
    Shah RA; Asatryan B; Sharaf Dabbagh G; Aung N; Khanji MY; Lopes LR; van Duijvenboden S; Holmes A; Muser D; Landstrom AP; Lee AM; Arora P; Semsarian C; Somers VK; Owens AT; Munroe PB; Petersen SE; Chahal CAA;
    Circulation; 2022 Jul; 146(2):110-124. PubMed ID: 35708014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustering of predicted loss-of-function variants in genes linked with monogenic disease can explain incomplete penetrance.
    Beaumont RN; Hawkes G; Gunning AC; Wright CF
    Genome Med; 2024 Apr; 16(1):64. PubMed ID: 38671509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
    Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
    JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.
    AlDubayan SH; Pyle LC; Gamulin M; Kulis T; Moore ND; Taylor-Weiner A; Hamid AA; Reardon B; Wubbenhorst B; Godse R; Vaughn DJ; Jacobs LA; Meien S; Grgic M; Kastelan Z; Markt SC; Damrauer SM; Rader DJ; Kember RL; Loud JT; Kanetsky PA; Greene MH; Sweeney CJ; Kubisch C; Nathanson KL; Van Allen EM; Stewart DR; Lessel D;
    JAMA Oncol; 2019 Apr; 5(4):514-522. PubMed ID: 30676620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting.
    Wright CF; West B; Tuke M; Jones SE; Patel K; Laver TW; Beaumont RN; Tyrrell J; Wood AR; Frayling TM; Hattersley AT; Weedon MN
    Am J Hum Genet; 2019 Feb; 104(2):275-286. PubMed ID: 30665703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing and characterization of 49,960 individuals in the UK Biobank.
    Van Hout CV; Tachmazidou I; Backman JD; Hoffman JD; Liu D; Pandey AK; Gonzaga-Jauregui C; Khalid S; Ye B; Banerjee N; Li AH; O'Dushlaine C; Marcketta A; Staples J; Schurmann C; Hawes A; Maxwell E; Barnard L; Lopez A; Penn J; Habegger L; Blumenfeld AL; Bai X; O'Keeffe S; Yadav A; Praveen K; Jones M; Salerno WJ; Chung WK; Surakka I; Willer CJ; Hveem K; Leader JB; Carey DJ; Ledbetter DH; ; Cardon L; Yancopoulos GD; Economides A; Coppola G; Shuldiner AR; Balasubramanian S; Cantor M; ; Nelson MR; Whittaker J; Reid JG; Marchini J; Overton JD; Scott RA; Abecasis GR; Yerges-Armstrong L; Baras A
    Nature; 2020 Oct; 586(7831):749-756. PubMed ID: 33087929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk.
    Vad OB; Monfort LM; Paludan-Müller C; Kahnert K; Diederichsen SZ; Andreasen L; Lotta LA; Nielsen JB; Lundby A; Svendsen JH; Olesen MS;
    JAMA Cardiol; 2024 Aug; 9(8):732-740. PubMed ID: 38922602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality.
    Patel AP; Dron JS; Wang M; Pirruccello JP; Ng K; Natarajan P; Lebo M; Ellinor PT; Aragam KG; Khera AV
    JAMA Cardiol; 2022 Jul; 7(7):723-732. PubMed ID: 35544052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Vascular Risk Factors and Genetic Factors With Penetrance of Variants Causing Monogenic Stroke.
    Cho BPH; Harshfield EL; Al-Thani M; Tozer DJ; Bell S; Markus HS
    JAMA Neurol; 2022 Dec; 79(12):1303-1311. PubMed ID: 36300346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population.
    Martin CL; Wain KE; Oetjens MT; Tolwinski K; Palen E; Hare-Harris A; Habegger L; Maxwell EK; Reid JG; Walsh LK; Myers SM; Ledbetter DH
    JAMA Psychiatry; 2020 Dec; 77(12):1276-1285. PubMed ID: 32697297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss-of-Function Variants in the Tumor-Suppressor Gene
    Olafsdottir T; Stacey SN; Sveinbjornsson G; Thorleifsson G; Norland K; Sigurgeirsson B; Thorisdottir K; Kristjansson AK; Tryggvadottir L; Sarin KY; Benediktsson R; Jonasson JG; Sigurdsson A; Jonasdottir A; Kristmundsdottir S; Jonsson H; Gylfason A; Oddsson A; Fridriksdottir R; Gudjonsson SA; Zink F; Lund SH; Rognvaldsson S; Melsted P; Steinthorsdottir V; Gudmundsson J; Mikaelsdottir E; Olason PI; Stefansdottir L; Eggertsson HP; Halldorsson BV; Thorsteinsdottir U; Agustsson TT; Olafsson K; Olafsson JH; Sulem P; Rafnar T; Gudbjartsson DF; Stefansson K
    Cancer Res; 2021 Apr; 81(8):1954-1964. PubMed ID: 33602785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian approach to determining penetrance of pathogenic SDH variants.
    Benn DE; Zhu Y; Andrews KA; Wilding M; Duncan EL; Dwight T; Tothill RW; Burgess J; Crook A; Gill AJ; Hicks RJ; Kim E; Luxford C; Marfan H; Richardson AL; Robinson B; Schlosberg A; Susman R; Tacon L; Trainer A; Tucker K; Maher ER; Field M; Clifton-Bligh RJ
    J Med Genet; 2018 Nov; 55(11):729-734. PubMed ID: 30201732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
    Momozawa Y; Sasai R; Usui Y; Shiraishi K; Iwasaki Y; Taniyama Y; Parsons MT; Mizukami K; Sekine Y; Hirata M; Kamatani Y; Endo M; Inai C; Takata S; Ito H; Kohno T; Matsuda K; Nakamura S; Sugano K; Yoshida T; Nakagawa H; Matsuo K; Murakami Y; Spurdle AB; Kubo M
    JAMA Oncol; 2022 Jun; 8(6):871-878. PubMed ID: 35420638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
    Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
    JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population.
    Aung N; Nicholls HL; Chahal CAA; Khanji MY; Rauseo E; Chadalavada S; Petersen SE; Munroe PB; Elliott PM; Lopes LR
    JAMA Cardiol; 2024 Nov; 9(11):964-972. PubMed ID: 39196575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.
    Johnston JJ; Rubinstein WS; Facio FM; Ng D; Singh LN; Teer JK; Mullikin JC; Biesecker LG
    Am J Hum Genet; 2012 Jul; 91(1):97-108. PubMed ID: 22703879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.